Stay updated on Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.

Latest updates to the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page
- Check4 days agoChange DetectedThe site footer’s revision label changed from v3.7.1 to v3.7.2. The study record content remains unchanged.SummaryDifference0.1%

- Check11 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check18 days agoChange DetectedThe record history now includes additional change categories (Study Design, Study Status, Study Identification, and Recruitment Status). The older recruitment status value 'Active, not recruiting' was removed.SummaryDifference0.8%

- Check32 days agoChange DetectedA new revision label 'Revision: v3.7.0' appears in the history, and the previous 'Revision: v3.6.6' entry is removed, indicating a software/version update on the page.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry v3.6.6 is added to the study record history. The previous revision v3.6.5 is removed from the history.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry, Revision: v3.6.5, has been added to the study's record history, replacing the previous Revision: v3.6.4. This reflects an update to the history metadata rather than changes to study data or content.SummaryDifference0.1%

Stay in the know with updates to Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.